to determine the association of qualitative and quantitative measurements of the myocardial infarct-related coronary narrowing with subsequent recurrent ischemia/reocclusion after successful thrombolysis , 47 patients treated with high-dose ( 150 mg ) tissue plasminogen activator over 6 to 8 hours were studied in the setting of acute myocardial infarction .
C0027051
myocardial infarct
C0032143
tissue plasminogen activator